/ database / Metabolic

10-Amino-1MQ

Also: NNMT inhibitor (long-form)

Less-studied cousin of 5-Amino-1MQ, marketed for body-composition support.

Evidence
anecdotal
Legal status
research only
Half-life
Estimated several hours
Routes
oral
What it is

10-Amino-1MQ targets the same NNMT pathway as 5-Amino-1MQ, with reported anecdotal preference for fat-loss focused protocols. Pre-clinical literature is sparse compared to the 5-position analog, and no human trials have been published.

Mechanism

Higher-mass analog of 5-Amino-1MQ — inhibits nicotinamide N-methyltransferase (NNMT), preserving NAD+ and SAM availability in adipocytes.

Outcomes it's matched to
Safety

Human safety profile unknown. Use only in research contexts.

  • Pregnancy
  • Active liver disease
Legal context

Research chemical. No human approval.

1:1 GUIDANCE

Have questions about this peptide?

Get free 1:1 guidance from a peptide professional before you start. They'll help you think through dosing, stacking, and whether this fits your goals.

REQUEST A CALL →
PepVault

An outcome-driven reference for modern peptides. Educational only — not medical advice, not a sales platform, not affiliated with any clinic.

Disclaimer: PepVault is an educational resource. Nothing on this site is medical advice. Many peptides discussed are research compounds and are not approved by the FDA or equivalent agencies. Always consult a qualified clinician before starting any protocol.

© 2026 PepVault